Your browser doesn't support javascript.
loading
Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide.
Lodé, Laurence; Ménard, Audrey; Flet, Laurent; Richebourg, Steven; Loirat, Marion; Eveillard, Marion; Le Bris, Yannick; Godon, Catherine; Theisen, Olivier; Gagez, Anne-Laure; Cartron, Guillaume; Commes-Maerten, Thérèse; Villemagne, Bruno; Luycx, Odile; Godmer, Pascal; Pellat-Deceunynck, Catherine; Soussi, Thierry; Béné, Marie C; Delaunay, Jacques; Peterlin, Pierre.
Afiliação
  • Lodé L; Hematology Biology, Montpellier University Hospital, France.
  • Ménard A; Hematology Biology, Nantes University Hospital, France.
  • Flet L; UMR CNRS5235, University of Montpellier.
  • Richebourg S; Bio2M team, Institut de Recherche en Medecine Regeneratrice, INSERM U1183, Hôpital Saint-Eloi, Montpellier, France.
  • Loirat M; Hematology Biology, Nantes University Hospital, France.
  • Eveillard M; Pharmacy Unit, Nantes University Hospital, France.
  • Le Bris Y; Cytogenetics, Québec University Hospital, Hôpital Saint Sacrement, Québec, Canada.
  • Godon C; Hematology Clinic, Nantes University Hospital, France.
  • Theisen O; Hematology Biology, Nantes University Hospital, France.
  • Gagez AL; Hematology Biology, Nantes University Hospital, France.
  • Cartron G; Hematology Biology, Nantes University Hospital, France.
  • Commes-Maerten T; Hematology Biology, Nantes University Hospital, France.
  • Villemagne B; Hematology Department, University Hospital, Montpellier, France.
  • Luycx O; UMR CNRS5235, University of Montpellier.
  • Godmer P; Hematology Department, University Hospital, Montpellier, France.
  • Pellat-Deceunynck C; Bio2M team, Institut de Recherche en Medecine Regeneratrice, INSERM U1183, Hôpital Saint-Eloi, Montpellier, France.
  • Soussi T; Hematology Clinic, CH La Roche-sur-Yon, France.
  • Béné MC; Hematology Clinic, CH Lorient, France.
  • Delaunay J; Hematology Clinic, CH Vannes, France.
  • Peterlin P; CRCINA, INSERM, CNRS, Angers University, Nantes University, France.
Haematologica ; 103(4): e143-e146, 2018 04.
Article em En | MEDLINE | ID: mdl-29269520
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Cromossomos Humanos Par 5 / Proteína Supressora de Tumor p53 / Deleção Cromossômica / Mutação Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Cromossomos Humanos Par 5 / Proteína Supressora de Tumor p53 / Deleção Cromossômica / Mutação Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article